🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers Clinical trials Xi’an
Clinical trial register · China

Clinical Trials in Xi’an, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Xi'an 41 Lanzhou 2 Ankang 1 Changsha 1 Hanzhong 1
Narrow the registerReset
Recruitment status
Phase
Site location
Xi'an41 Lanzhou2 Ankang1 Changsha1 Hanzhong1
All 16 locations
Target enrolment
to

Trials with a site in Xi’an

41 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Intravenous rhPro-UK Before Stroke Thrombectomy in the Extended Time Window (BRIDGE-PUK EXTEND)
NCT07389460Acute Ischemic Stroke
First Affiliated Hospital Xi'an Jiaotong University
Phase 3
820
Lanzhou, Shijiazhuang, Zhengzhou, Loudi, Dalian, Xining, Xi'an, Taiyuan
2026-04-07
Not yet open
Novel Bispecific AbTCR (Anti-CD19/CD22)-T Cells in Relapsed or Refractory B-cell Lymphoma
NCT07168291Diffuse Large B Cell Lymphoma (DLBCL), Follicular Lymphoma ( FL), Burkitt Lymphoma
First Affiliated Hospital Xi'an Jiaotong University
Phase EARLY_PHASE1
3
Xi'an
2025-12-31
Recruiting
Adebrelimab With Famitinib and Chemotherapy as Neoadjuvant Therapy for ESCC
NCT07796113Esophageal Squamous Cell Carcinoma
First Affiliated Hospital Xi'an Jiaotong University
Phase 2
24
Xi'an
2025-10-30
Recruiting
Remote Ischemic Conditioning for Acute Moderate Ischemic Stroke Due to Large Artery Atherosclerosis
NCT06775782Acute Ischemic Stroke
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
1,150
Xi'an
2025-08-10
Recruiting
Early Use of Realgar-Indigo Naturalis Formula (RIF) Combined With All-trans Retinoic Acid (ATRA) for Treating Acute Promyelocytic Leukemia (APL).
NCT07503730APL
First Affiliated Hospital Xi'an Jiaotong University
Phase 3
224
Xi'an
2025-06-01
Recruiting
Efficacy and Safety of Leymovir Versus Valganciclovir in Prevention of Cytomegalovirus Infection and Cytomegalovirus Disease in Chinese Kidney Transplant Recipients
NCT07266467Kidney Transplant
First Affiliated Hospital Xi'an Jiaotong University
Phase 4
290
Xi'an
2025-05-13
Not yet open
Hypotension Prediction Index and Intraoperative Hypotension Incidence
NCT06909786Intraoperative Hypotension
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
100
Xi'an
2025-04-01
By invitation
Randomized Controlled Study on the Safety and Efficacy of Phage Cocktail in the Treatment of Multidrug-Resistant Bacterial Skin Infections
NCT07619924Phage Therapy, Bacteriophage Therapy, Skin and Soft Tissue Infections
First Affiliated Hospital Xi'an Jiaotong University
Phase EARLY_PHASE1
150
Xi'an
2025-01-15
Not yet open
Acute Cerebrovascular Events in Patients Undergoing Catheter Ablation
NCT05694273Arrhythmia, Acute Cerebrovascular Disease
First Affiliated Hospital Xi'an Jiaotong University
Observational
2,000
Xi'an
2025-01-15
Not yet open
Abdominal Transcutaneous Electrical Acupoint Stimulation on Children With Autism Spectrum Disorder
NCT06763237Autism Spectrum Disorder, Autism in Children
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
42
Xi'an
2025-01-10
Recruiting
Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort Study
NCT07079150Hepatitis B, Chronic (CHB), Hepatitis B, Hepatitis B Virus (HBV)
First Affiliated Hospital Xi'an Jiaotong University
Observational
1,500
Xi'an
2025-01-01
Not yet open
Risk Stratification Value of Biomarkers in Patients With Ventricular Arrhythmias
NCT05965375Ventricular Arrythmia
First Affiliated Hospital Xi'an Jiaotong University
Observational
5,000
Xi'an
2024-12-31
Not yet open
Response of Intracardiac Thrombus to Anticoagulants in Patients With Non-valvular Atrial Fibrillation (LYSIS)
NCT06141538Atrial Fibrillation, Intracardiac Thrombus
First Affiliated Hospital Xi'an Jiaotong University
Observational
500
Xi'an
2024-12-31
Not yet open
Deep Learning for Intelligent Identification of Arrhythmias
NCT05967546Arrhythmia
First Affiliated Hospital Xi'an Jiaotong University
Observational
4,000
Xi'an
2024-12-30
Recruiting
Ursodeoxycholic Acid Attenuates Statin-Induced Impaired Glucose Tolerance
NCT06684106Hyperlipidemia, Ursodeoxycholic Acid, Statin Therapy, Glucose Intolerance
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
128
Xi'an
2024-11-25
Not yet open
Risk Stratification and Early Prevention Strategies for Non-compaction of Ventricular Myocardium (CAPTAIN)
NCT06504056Isolated Noncompaction of the Ventricular Myocardium
First Affiliated Hospital Xi'an Jiaotong University
Observational
2,000
Xi'an
2024-10-30
Recruiting
Intravascular Ultrasound-Guided PCI in Patients With Chronic Kidney Disease
NCT06567938Coronary Artery Disease, Chronic Kidney Diseases
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
1,528
Xi'an
2024-07-25
Not yet open
Clinical Study of Irinotecan Liposome Combination Therapy for Advanced Gastric Cancer
NCT06499610Gastric Cancer
First Affiliated Hospital Xi'an Jiaotong University
Phase 4
44
Xi'an
2024-07-15
Recruiting
Effects of Remote Ischemic Preconditioning on Peripheral Blood Biomarkers in Healthy Adults (EMINENT)
NCT05957523Ischemic Preconditioning
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
80
Xi'an
2024-06-27
Recruiting
Prognosis of Patients With Infective Endocarditis and Risk Stratification Value of Biomarkers (ENDEAVOR)
NCT05965362Infective Endocarditis
First Affiliated Hospital Xi'an Jiaotong University
Observational
2,000
Xi'an
2024-05-09
Recruiting
Risk Stratification and New Early Prevention and Treatment Strategies for Patients With Cardiomyopathy (STRENGTH)
NCT06352320Cardiomyopathies
First Affiliated Hospital Xi'an Jiaotong University
Observational
500
Xi'an
2024-05-09
Recruiting
Risk Stratification, Early Prevention and Treatment Strategies for Arrhythmogenic Cardiomyopathy
NCT06352307Arrhythmogenic Cardiomyopathy
First Affiliated Hospital Xi'an Jiaotong University
Observational
1,500
Xi'an
2024-04-09
Recruiting
Safety and Efficacy of XJ-Procedure in Patients With Acute Type A Aortic Dissection Surgery
NCT06199401Type A Aortic Dissection, Complication of Surgical Procedure, Aortic Diseases
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
680
Xi'an
2024-01-11
Recruiting
Cohort Study of Clinical and Neuroimaging Characteristics for BPPV Patients in China
NCT06228196BPPV, Vertigo, Vertigo, Peripheral
First Affiliated Hospital Xi'an Jiaotong University
Observational
150
Xi'an
2024-01-08
Recruiting
Magnetic Resonance Imaging Study on Young and Middle-aged Patients With Cervical Spondylotic Pain
NCT06217029Neck Pain
First Affiliated Hospital Xi'an Jiaotong University
Observational
80
Xi'an
2024-01-06
Recruiting
Safety and Efficacy of Remote Ischemic Conditioning for Patients Taking Off-pump Coronary Artery Bypass Grafting
NCT06141525Coronary Artery Bypass Grafting, Remote Ischemic Conditioning, Ischemia-Reperfusion Injury
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
648
Xi'an
2023-11-22
Recruiting
Clinical Characteristics and Prognosis of Aortic Dissection in China (CLASSIC)
NCT05999188Aortic Dissection
First Affiliated Hospital Xi'an Jiaotong University
Observational
100
Xi'an
2023-10-30
Recruiting
NGGT006 Gene Therapy for Homozygous Familial Hypercholesterolemia
NCT06125847Homozygous Familial Hypercholesterolemia
First Affiliated Hospital Xi'an Jiaotong University
Phase EARLY_PHASE1
21
Xi'an
2023-10-29
Recruiting
Characteristics of Cardiac Tumor and the Risk Stratification of Subsequent Adverse Events (UNIQUE)
NCT06100328Cardiac Tumor
First Affiliated Hospital Xi'an Jiaotong University
Observational
40
Xi'an
2023-10-26
Recruiting
Risk Stratification Value of Biomarkers in Patients With Myocarditis
NCT06010199Myocarditis
First Affiliated Hospital Xi'an Jiaotong University
Observational
1,000
Xi'an
2023-08-25
Recruiting
Prognosis of Heart Transplanted Patients With Heart Failure
NCT05775432Heart Failure
First Affiliated Hospital Xi'an Jiaotong University
Observational
1,000
Xi'an
2023-04-23
Not yet open
Clinical Study of Improved BEAM Conditioning Regimen for ASCT in Lymphoma
NCT05681403Lymphoma, Autologous Hematopoietic Stem Cell Transplantation
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
53
Xi'an
2023-01-15
Recruiting
Registry Study for Optimal Management of Liver Failure in the Chinese Population
NCT05740696Liver Failure
First Affiliated Hospital Xi'an Jiaotong University
Observational
500
Xi'an, Ankang, Changsha, Hanzhong, Jinan, Lanzhou, Weinan, Xianyang
2023-01-06
Recruiting
99mTc-P137 SPECT/CT in Prostate Cancer
NCT05672485Prostate Cancer
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
40
Xi'an
2023-01-05
Recruiting
Prognosis Prediction System of Patients With Cardiovascular and Cerebrovascular Diseases Based on Multi-omics
NCT06001073Coronary Artery Disease, Arrhythmias, Cardiac, Heart Valve Diseases, Aortic Dissection
First Affiliated Hospital Xi'an Jiaotong University
Observational
25,000
Xi'an
2022-12-05
Active, closed
To Explore the Influencing Factors and Solutions for Patients With Plaque Psoriasis Undergoing Relapse
NCT07730619Plaque Psoriasis, Biologic Agents, Relapse, Influence Factors
First Affiliated Hospital Xi'an Jiaotong University
Observational
140
Xi'an
2022-12-01
Recruiting
Evaluation and Prediction of the Effect of EECP on HR-NICE Patients
NCT05718622Stroke, Ischemic
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
100
Xi'an
2022-11-10
Not yet open
Neoadjuvant PDT in the Treatment of Cholangiocarcinoma
NCT04824742Cholangiocarcinoma Resectable
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
50
Xi'an
2021-04-01
Recruiting
Evaluation of the Castor Single Branch Stent Graft in Treatment of Acute Aortic Syndrome
NCT05965453Acute Aortic Syndrome
First Affiliated Hospital Xi'an Jiaotong University
Observational
205
Xi'an
2018-06-01
Recruiting
Peripheral Blood Lipidomic and Ceramide Profiles in Atrial Fibrillation
NCT07757282Atrial Fibrillation (AF)
First Affiliated Hospital Xi'an Jiaotong University
Observational
200
Xi'an
2017-06-15
Active, closed
Establishment of a Model for Predicting the Prognosis of HBV-related Decompensated Liver Cirrhosis Based on RFH-NPT
NCT05513651Liver Cirrhosis, Malnutrition
First Affiliated Hospital Xi'an Jiaotong University
Observational
2,000
Xi'an
2016-07-01
Rows per page Showing 1–41 of 41
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/xi-an

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 41 of those studies with a site in Xi’an that also match the filters currently applied.

How many clinical trials are recruiting in Xi’an?

27 of the 41 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 11 have not yet opened recruitment, 2 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Xi’an), 41 studies
PhaseStudiesRecruitingShare
Observational211451.2%
Not applicable12829.3%
Phase EARLY_PHASE1317.3%
Phase 3224.9%
Phase 4214.9%
Phase 2112.4%

Most active sponsors

Lead sponsors with the most studies (Xi’an)
Lead sponsorStudiesRecruiting
First Affiliated Hospital Xi'an Jiaotong University4127
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.